Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Dagada

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Presse Medicale (Paris, France : 1983)|August 12, 2003
[Management of cancer patients by general practitioners. Results of a survey among 422 physicians in Aquitaine]Corinne Dagada, Simone Mathoulin-Pélissier, Alain Monnereau, et al.
Bulletin Du Cancer|February 16, 2002
[Update on soft tissue sarcomas]Binh Nguyen Bui, Reza Tabrizi, Corinne Dagada, et al.
Cancers|September 9, 2020
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML PatientsGabriel Etienne, Stéphanie Dulucq, Fréderic Bauduer, et al.
Cancer Medicine|May 14, 2021
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitorsGabriel Etienne, Carole Faberes, Fréderic Bauduer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|August 12, 2003
[Management of cancer patients by general practitioners. Results of a survey among 422 physicians in Aquitaine]Corinne Dagada, Simone Mathoulin-Pélissier, Alain Monnereau, et al.
Bulletin Du Cancer|February 16, 2002
[Update on soft tissue sarcomas]Binh Nguyen Bui, Reza Tabrizi, Corinne Dagada, et al.
Cancers|September 9, 2020
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML PatientsGabriel Etienne, Stéphanie Dulucq, Fréderic Bauduer, et al.
Cancer Medicine|May 14, 2021
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitorsGabriel Etienne, Carole Faberes, Fréderic Bauduer, et al.
Pageof 1